Suchergebnisse - "Disability worsening"

PubPharm (26)

1

Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis

enthalten in: Journal of neurology | 2024

von Rosenstein, I. | Nordin, A. | Sabir, H. | +4

2

Association between sun exposure habits and disease progression in multiple sclerosis

enthalten in: European journal of neurology | 2024

von Wu, J. | Olsson, T. | Alfredsson, L. | +1

3

Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis

enthalten in: Gut microbes | 2023

von Devolder, L. | Pauwels, A. | Van Remoortel, A. | +6

4

Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis

in: Gut Microbes | 2023

von Lindsay Devolder | Ayla Pauwels | Ann Van Remoortel | +6

5

Overall Disability Response Score : An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Chang, I. | Kappos, L. | Giovannoni, G. | +8

6

Natalizumab treatment and pregnancy in multiple sclerosis : A reappraisal of maternal and infant outcomes after 6 years

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Portaccio, E. | Pastò, L. | Razzolini, L. | +23

7

Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Portaccio, E. | Tudisco, L. | Pastò, L. | +43

8

Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis : Post Hoc Analysis of the CARE-MS Studies

enthalten in: Neurology and therapy | 2021

von Hunter, S. | Aburashed, R. | Alroughani, R. | +16

9

A matter of atrophy : differential impact of brain and spine damage on disability worsening in multiple sclerosis

enthalten in: Journal of neurology | 2021

von Ruggieri, S. | Petracca, M. | De Giglio, L. | +7

10

Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies

enthalten in: Neurology and Therapy | 2021

von Hunter, S. | Aburashed, R. | Alroughani, R. | +15